Correlation Between Arcosa and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcosa and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcosa and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcosa Inc and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Arcosa and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcosa with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcosa and Sartorius Stedim.

Diversification Opportunities for Arcosa and Sartorius Stedim

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Arcosa and Sartorius is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Arcosa Inc and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Arcosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcosa Inc are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Arcosa i.e., Arcosa and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Arcosa and Sartorius Stedim

Considering the 90-day investment horizon Arcosa Inc is expected to generate 0.88 times more return on investment than Sartorius Stedim. However, Arcosa Inc is 1.13 times less risky than Sartorius Stedim. It trades about 0.08 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.04 per unit of risk. If you would invest  8,771  in Arcosa Inc on June 4, 2025 and sell it today you would earn a total of  867.00  from holding Arcosa Inc or generate 9.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Arcosa Inc  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Arcosa Inc 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Arcosa Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady fundamental indicators, Arcosa may actually be approaching a critical reversion point that can send shares even higher in October 2025.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Arcosa and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcosa and Sartorius Stedim

The main advantage of trading using opposite Arcosa and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcosa position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Arcosa Inc and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments